Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA DIVIS LABORATORIES ORCHID PHARMA/
DIVIS LABORATORIES
 
P/E (TTM) x 41.8 66.0 63.3% View Chart
P/BV x 7.7 7.1 107.7% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 ORCHID PHARMA   DIVIS LABORATORIES
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-23
DIVIS LABORATORIES
Mar-23
ORCHID PHARMA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs4394,641 9.4%   
Low Rs2732,730 10.0%   
Sales per share (Unadj.) Rs163.1292.6 55.8%  
Earnings per share (Unadj.) Rs13.568.7 19.7%  
Cash flow per share (Unadj.) Rs27.081.6 33.0%  
Dividends per share (Unadj.) Rs030.00 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs168.7480.9 35.1%  
Shares outstanding (eoy) m40.82265.47 15.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.212.6 17.3%   
Avg P/E ratio x26.353.7 49.0%  
P/CF ratio (eoy) x13.245.2 29.2%  
Price / Book Value ratio x2.17.7 27.5%  
Dividend payout %043.7 0.0%   
Avg Mkt Cap Rs m14,522978,378 1.5%   
No. of employees `000NANA-   
Total wages/salary Rs m6549,750 6.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,65977,675 8.6%  
Other income Rs m1943,447 5.6%   
Total revenues Rs m6,85381,122 8.4%   
Gross profit Rs m1,23523,691 5.2%  
Depreciation Rs m5483,432 16.0%   
Interest Rs m32920 1,678.7%   
Profit before tax Rs m55223,686 2.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m05,453 0.0%   
Profit after tax Rs m55218,234 3.0%  
Gross profit margin %18.530.5 60.8%  
Effective tax rate %023.0 0.0%   
Net profit margin %8.323.5 35.3%  
BALANCE SHEET DATA
Current assets Rs m5,01097,437 5.1%   
Current liabilities Rs m3,71915,331 24.3%   
Net working cap to sales %19.4105.7 18.3%  
Current ratio x1.36.4 21.2%  
Inventory Days Days578 684.5%  
Debtors Days Days1,180842 140.0%  
Net fixed assets Rs m7,24251,128 14.2%   
Share capital Rs m408531 76.9%   
"Free" reserves Rs m6,478127,140 5.1%   
Net worth Rs m6,886127,671 5.4%   
Long term debt Rs m1,4880-   
Total assets Rs m12,252148,565 8.2%  
Interest coverage x2.71,209.5 0.2%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.50.5 104.0%   
Return on assets %7.212.3 58.6%  
Return on equity %8.014.3 56.2%  
Return on capital %10.518.6 56.7%  
Exports to sales %81.985.7 95.6%   
Imports to sales %37.619.8 189.7%   
Exports (fob) Rs m5,45266,537 8.2%   
Imports (cif) Rs m2,50115,378 16.3%   
Fx inflow Rs m5,45266,537 8.2%   
Fx outflow Rs m2,72615,715 17.3%   
Net fx Rs m2,72650,822 5.4%   
CASH FLOW
From Operations Rs m18324,597 0.7%  
From Investments Rs m-312-27,076 1.2%  
From Financial Activity Rs m312-7,972 -3.9%  
Net Cashflow Rs m183-10,451 -1.8%  

Share Holding

Indian Promoters % 69.8 51.9 134.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.6 36.7 50.7%  
FIIs % 4.1 14.9 27.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.2 48.1 62.7%  
Shareholders   36,931 354,482 10.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Orchid Pharma vs Divis Laboratories

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Orchid Pharma vs Divis Laboratories Share Price Performance

Period Orchid Pharma Divis Laboratories S&P BSE HEALTHCARE
1-Day -0.40% 2.14% 1.18%
1-Month -14.06% -2.15% -0.75%
1-Year 173.54% 22.51% 61.82%
3-Year CAGR -23.64% -1.38% 18.16%
5-Year CAGR 184.58% 15.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the Orchid Pharma share price and the Divis Laboratories share price.

Moving on to shareholding structures...

The promoters of Orchid Pharma hold a 69.8% stake in the company. In case of Divis Laboratories the stake stands at 51.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Orchid Pharma and the shareholding pattern of Divis Laboratories.

Finally, a word on dividends...

In the most recent financial year, Orchid Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Divis Laboratories paid Rs 30.0, and its dividend payout ratio stood at 43.7%.

You may visit here to review the dividend history of Orchid Pharma, and the dividend history of Divis Laboratories.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.